References
- Zendenman AJW, van Venrooij WJ, Pruijin GJM. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 2006;45:20–5.
- Vossenaar ER, van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clinical and Applied Immunology Reviews 2004;4:239–62.
- Coenen D, Verschueren P, Westhovens R, Bossuyt X. Technical and diagnostic performance of 6 assays for measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clinical Chemistry 2007;53(3):498–504.
- Product information Anti-CCP edition 2009–04, Roche diagnostics data on file at Roche.
- Chan EKL, Fritzler MV, Wiik A, Andrade LEC, Reeves WH, Tincani A, Meroni PL. The IUIS/WHO/AF/CDC committee for standardization of autoantibodies in rheumatic and related diseases. Autoimmunity reviews 2007;6:577–80.
- Passing H, Bablok W. A general regression procedure for method transformation. Journal of Clinical Chemistry and Clinical Biochemistry 1988;26:783–90.
- Pruijn GJM, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arhritis Research Therapy 2010;12:203.